BSEBoard Meeting▲ PositiveResults10 Aug 2026
PC Jeweller Ltd
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the unaudited standalone and consolidated financial results of the Company for ....
PC Jeweller Ltd has reported robust operational performance in Q1FY27 with a 21% YoY increase in consolidated revenues to Rs 877 crores, driven by improved customer demand and footfall. The company has also made significant progress in its deleveraging journey, repaying 7 out of 14 consortium banks and discharging 96% of the outstanding debt of the remaining 7 banks. The company plans to raise up to Rs 1,000 crore through a QIP to support future growth opportunities and strengthen its financial flexibility.
NSEUpdates▲ PositiveResults10 Aug 2026
The India Cements Limited
Updates
The India Cements Limited has informed the Exchange regarding 'Chairman Speech at the 80th Annual General Meeting of the Company'. The Chairman's Speech highlights the Company's performance, growth opportunities, and sustainability efforts.
NSEOutcome of Board Meeting▲ PositiveResults10 Aug 2026
Triveni Turbine Limited
Outcome of Board Meeting
Triveni Turbine Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026, with a net profit of ₹511 crore and earnings per share of ₹1.60.
NSEOutcome of Board Meeting▲ PositiveResults10 Aug 2026
PC Jeweller Limited
Outcome of Board Meeting
PC Jeweller Limited has submitted its financial results for the quarter ended June 30, 2026, showing a 21% year-on-year increase in consolidated revenues to Rs 877 crores. The company's consolidated operating PAT rose to Rs 213 crores, registering a growth of 168%. The company has made significant progress in its deleveraging journey and has fully repaid and discharged the debt of 7 out of 14 consortium banks.
BSECompany Update▲ PositiveResults10 Aug 2026
HealthCare Global Enterprises Ltd
Please find attached herewith the Transcript of Earnings Call held on August 07, 2026, with Analysts/Investors to discuss the Unaudited Financial Results (Standalone and Consolidated) of ....
HealthCare Global Enterprises Ltd has announced its unaudited financial results for Q1 FY27, with revenue of INR6,951 million, representing a 13% year-on-year growth. The company has also started FY27 on a strong note, with 16 out of its 25 centers delivering their highest ever quarterly revenues.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026
KEI Industries Limited
Analysts/Institutional Investor Meet/Con. Call Updates
KEI Industries Limited has announced its Q1 FY27 earnings, with net sales growing 23% to INR3,185 crores and operating margin improving to 12.43%. EBITDA grew 39.5% to INR415 crores, and profit after tax increased 40% to INR274 crores. The company has a pending order book of INR4,292 crores and a long-term rating of AA+ from CARE India Rating and Research.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026
Healthcare Global Enterprises Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Healthcare Global Enterprises Limited has informed the Exchange about Transcript of the Earnings Call held on August 07, 2026 to discuss the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026
CORONA Remedies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
CORONA Remedies Limited reported a 21.9% year-on-year revenue growth in Q1 FY27, surpassing its stated growth guidance of 15%. The company's India business delivered an impressive 22.7% year-on-year revenue growth, significantly outperforming the Indian Pharmaceutical Market, which grew by 11.6% during the same period.
BSEResult▲ PositiveResults10 Aug 2026
Dharani Finance Ltd
Un-audited financial results for the quarter ended 30th June 2026
Dharani Finance Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit of Rs. 20.35 lakhs. The company's revenue from operations was Rs. 41.90 lakhs, with interest income of Rs. 21.03 lakhs and dividend income of Rs. 0.06 lakhs. The company's expenses were Rs. 15.78 lakhs, with finance costs of Rs. 14.90 lakhs and employee benefits expenses of Rs. 4.79 lakhs. The company's profit before tax was Rs. 26.74 lakhs, with a tax expense of Rs. 639 lakhs. The company's profit for the period was Rs. 20.35 lakhs.
NSEUpdates▲ PositiveResults10 Aug 2026
JK Tyre & Industries Limited
Updates
JK Tyre & Industries Limited's Chairman & Managing Director's Statement at the 73rd Annual General Meeting highlights the company's performance, expansion plans, and sustainability focus.
BSECompany Update▲ PositiveResults10 Aug 2026
Corona Remedies Ltd
Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the first quarter and three months ended June 30, 2026
Corona Remedies Ltd reported a 21.9% year-on-year revenue growth in Q1 FY27, surpassing its stated growth guidance of 15%. The company's India business delivered an impressive 22.7% year-on-year revenue growth, significantly outperforming the Indian Pharmaceutical Market (IPM) which grew by 11.6% during the same period.
NSEPress Release▲ PositiveResults10 Aug 2026
IOL Chemicals and Pharmaceuticals Limited
Press Release
IOL Chemicals and Pharmaceuticals Limited has announced its Q1 FY27 results, reporting a record quarterly performance with highest-ever revenue, driven by improved capacity utilisation, favourable product mix and operational efficiencies. The company's Pharmaceuticals business saw a 43% YoY revenue growth and 72% YoY EBIT growth, while the Chemicals business delivered 29% YoY revenue growth and 193% YoY EBIT growth.
BSECompany Update▲ PositiveResults10 Aug 2026
IOL Chemicals & Pharmaceuticals Ltd
Press Release- Financial Results for the quarter ended 30th June 2026
IOL Chemicals & Pharmaceuticals Ltd reported its Q1 FY27 results, with revenue from operations increasing 37.1% YoY to ₹756.3 Cr, EBITDA rising 60.7% YoY to ₹111.7 Cr, and PAT increasing 89.9% YoY to ₹64.5 Cr. The company's Pharmaceuticals business saw a 43% YoY revenue growth and 72% YoY EBIT growth, driven by improved capacity utilisation, favourable product mix, and operational efficiencies.
BSECompany Update▲ PositiveResults10 Aug 2026
VL E-Governance & IT Solutions Ltd
RESULTS PERFORMANCE UPDATE PRESENTATION - "Q1 FY2026-27 RESULTS UPDATE"
VL E-Governance & IT Solutions Ltd has announced its Q1 FY2026-27 results, showing improved operational resilience through disciplined cost management, with total expenses reduced to 124.46 from 181.15. The company has also signed an MoU with Ekansh Concepts to explore new business opportunities in the Government's e-Governance initiatives.
BSECompany Update▲ PositiveResults10 Aug 2026
Lumax Auto Technologies Ltd
Investor Release of Financial Results for the 1st Quarter ended June 30, 2026.
Lumax Auto Technologies Ltd reported a 33% YoY revenue growth to ₹1,364 crore in Q1FY27, with EBITDA and PAT before minority interest growing by 51% and 83% YoY respectively. The company's revenue growth was driven by scale-up of existing products and increasing penetration of value-added product portfolio.
NSEInvestor Presentation▲ PositiveResults10 Aug 2026
S Chand And Company Limited
Investor Presentation
S Chand And Company Limited has released its Q1 FY2027 investor presentation, highlighting a strong quarter for the School Education segment with multiple repeat orders and Rs91m revenues from content licensing. The company has also taken a conscious decision to advance paper purchases due to higher prices and elongated shipping timelines, and has maintained a net debt-free position with an increased net cash balance of Rs1,182m.
BSECompany Update▲ PositiveResults10 Aug 2026
S Chand and Company Ltd
S Chand - Q1 FY 27 - Investor Presentation
S Chand and Company Ltd reported a strong Q1 FY27 with revenue growth, improved cash flow, and a net cash balance of Rs1,182m. The company expects growth acceleration in the school education segment and aims to achieve a net cash balance of Rs1,500m by the end of FY27.
NSEPress Release▲ PositiveResults10 Aug 2026
Lumax Auto Technologies Limited
Press Release
Lumax Auto Technologies Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, with a revenue growth of 33% YoY to ₹1,364 crore, and a PAT (before minority interest) growth of 83% YoY to ₹99 crores.
BSECompany Update▲ PositiveResults10 Aug 2026
NINtec Systems Ltd
Press Release - Declaration of Financial results for quarter ended 30th June, 2026
NINtec Systems Ltd has announced its unaudited consolidated financial results for the quarter ended 30 June 2026, showing revenue growth of 18.1% and operating profit growth of 40.9%, with employee cost decreasing by 4.8%. The company's operating margin expanded by 420 basis points to 25.9%.
NSEPress Release▲ PositiveResults10 Aug 2026
NINtec Systems Limited
Press Release
NINtec Systems Limited has announced its unaudited consolidated financial results for Q1 FY27, with revenue up 18.1% and operating profit up 40.9%. Employee cost was lower year-on-year, even as revenue rose meaningfully. The margin expansion of 420 bps to 25.9% is attributed to the company's AI-first execution.